Serum phospholipid eicosapentaenoic acid as the prognostic factor in patients with non Hodgkin's lymphoma

被引：0
|
作者：
Cvetkovic, Z.
Cvetkovic, B.
Celeketic, D.
Vukov, V.
Petrovic, M.
机构：
[1] Clin Hosp Ctr Zemun, Haematol Dpt, Belgrade, Serbia
[2] Inst Med Res, Belgrade, Serbia
[3] Clin Ctr Serbia, Inst Haematol, Belgrade, Serbia
来源：
BLOOD REVIEWS | 2007年 / 21卷
关键词：
D O I：
10.1016/S0268-960X(07)70110-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [41] Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma
    Kok, M
    Bonfrer, JM
    Korse, CM
    de Jong, D
    Kersten, MJ
    TUMOR BIOLOGY, 2003, 24 (01) : 53 - 60
  • [42] Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma
    Niitsu, N
    Okabe-Kado, J
    Okamoto, M
    Takagi, T
    Yoshida, T
    Aoki, S
    Hirano, M
    Honma, Y
    BLOOD, 2001, 97 (05) : 1202 - 1210
  • [43] The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Park, Dae Jin
    Ye, Byeong Jin
    Kim, Yang Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 43 - 49
  • [44] Prognostic significance of serum Beta 2 Microglobulin in Non-Hodgkin Lymphoma
    Gupta, G.
    Ghalaut, V. S.
    Lokanathan, V.
    Sharma, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft
    Tarella, C
    Caracciolo, D
    Gavarotti, P
    Argentino, C
    Zallio, F
    Corradini, P
    Novero, D
    Magnani, C
    Pileri, A
    BONE MARROW TRANSPLANTATION, 2000, 26 (11) : 1185 - 1191
  • [46] LGALS3 as a prognostic factor for classical Hodgkin's lymphoma
    Koh, Young Wha
    Jung, Se Jin
    Park, Chan-Sik
    Yoon, Dok Hyun
    Suh, Cheolwon
    Huh, Jooryung
    MODERN PATHOLOGY, 2014, 27 (10) : 1338 - 1344
  • [47] Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft
    C Tarella
    D Caracciolo
    P Gavarotti
    C Argentino
    F Zallio
    P Corradini
    D Novero
    C Magnani
    A Pileri
    Bone Marrow Transplantation, 2000, 26 : 1185 - 1191
  • [48] Topoisomerase IIα expression is an independent prognostic factor in Hodgkin's lymphoma
    Doussis-Anagnostopoulou, Ipatia
    Vassilakopoulos, Theodoros
    Thymara, Irini
    Kaklamanis, Loukas
    Korkolopoulou, Penelope
    Androulaki, Athina
    Patsouris, Efstratios
    Kittas, Christos
    Pangalis, Gerassimos
    VIRCHOWS ARCHIV, 2007, 451 (02) : 118 - 118
  • [49] Topoisomerase IIα expression as an independent prognostic factor in Hodgkin's lymphoma
    Doussis-Anagnostopoulou, Ipatia A.
    Vassilakopoulos, Theodoros P.
    Thymara, Irini
    Korkolopoulou, Penelope
    Angelopoulou, Maria K.
    Siakantaris, Marina P.
    Kokoris, Styliani I.
    Dimitriadou, Evangelia M.
    Kalpadakis, Christina
    Matzouranis, Marina
    Kaklamanis, Loukas
    Panayiotidis, Panayiotis
    Kyrtsonis, Marie-Christine
    Androulaki, Athina
    Patsouris, Efstratios
    Kittas, Christos
    Pangalis, Gerassimos A.
    CLINICAL CANCER RESEARCH, 2008, 14 (06) : 1759 - 1766
  • [50] Prognostic Value of Pleural Effusion in Hodgkin's Lymphoma Patients
    Bhatt, Nidhi
    Brandt, Gregory
    Niebrugge, Daniel
    Khan, Aziz U.
    BLOOD, 2015, 126 (23)
12345